Ray Dalio’s Medpace MEDP Stock Holding History

Ray Dalio’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.8M	Buy	41,135 +6,833	+20%	+$3.5M	0.09%	157
2025 Q4	$19.3M	Buy	34,302 +1,072	+3%	+$609K	0.07%	217
2025 Q3	$17.1M	Buy	+33,230	New	+$14.5M	0.07%	229

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Ray Dalio's MEDP Position: Q1 2026 in Review

Ray Dalio increased its Medpace (MEDP) stake by 20% in Q1 2026, buying an estimated $3.5M and bringing the position to 41,135 shares worth $19.8M. The position accounts for 0.09% of the portfolio, ranked #157.

Ray Dalio first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. 731 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Ray Dalio held 41,135 shares of Medpace worth $19.8M as of Q1 2026.
Ray Dalio bought 6,833 Medpace shares in Q1 2026, an estimated $3.5M.
Medpace made up 0.09% of Ray Dalio's portfolio in Q1 2026, its #157 holding.
Ray Dalio first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
731 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.